Article Text

Download PDFPDF
General medicine
Risk score identifies patients who will benefit from prolonged dual antiplatelet therapy

Statistics from


  • Contributors KFF and RWY contributed to the supervision, drafting and critical revision of this manuscript.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.